By Counterforce Health Team in Takhzyro (lanadelumab-flyo) —

Getting Takhzyro (lanadelumab-flyo) Covered by Cigna in Florida: Complete Prior Authorization & Appeal Guide

Answer Box: Getting Takhzyro Covered by Cigna in Florida

Eligibility: Cigna covers Takhzyro (lanadelumab-flyo) for hereditary angioedema (HAE) types I/II with prior authorization. You need documented low C1-INH levels (<50%) and low C4, plus prescription by an allergist/immunologist.

Fastest path: Submit PA through your specialist with lab results, attack logs, and medical necessity letter. Approval typically takes 5-15 business days.

First step today: Contact your HAE specialist to initiate the prior authorization process and gather required documentation.

Table of Contents

  1. Plan Types & Coverage Differences
  2. Formulary Status & Tier Placement
  3. Prior Authorization Requirements
  4. Specialty Pharmacy Requirements
  5. Cost Sharing & Patient Expenses
  6. Step-by-Step Approval Process
  7. Common Denial Reasons & Solutions
  8. Appeals Process in Florida
  9. When to Escalate
  10. FAQ

Plan Types & Coverage Differences

Cigna offers several plan types in Florida, each with distinct requirements for Takhzyro coverage:

Cigna HMO Plans

  • Referral required: Must get PCP referral to see HAE specialist
  • Network restriction: In-network providers only (except emergencies)
  • Coverage: Prior authorization required, same clinical criteria as other plans

Cigna PPO Plans

  • No referral needed: Direct access to specialists
  • Network flexibility: Can see out-of-network providers at higher cost
  • Coverage: Prior authorization required with same medical necessity criteria

Cigna EPO Plans

  • No referral needed: Direct specialist access
  • Network restriction: In-network only (like HMO)
  • Coverage: Prior authorization required, standard criteria apply

Medicaid Managed Care

  • Stricter requirements: Often requires PCP referral and additional documentation
  • Enhanced review: More intensive prior authorization process for high-cost drugs
  • Network limits: Must use enrolled Medicaid providers
Tip: Regardless of plan type, all Cigna members need the same clinical documentation for Takhzyro approval. The main differences are referral requirements and network restrictions.

Formulary Status & Tier Placement

Takhzyro is classified as a Specialty Tier medication across Cigna's Florida formularies:

Plan Type Tier Level Coverage Status PA Required
4-Tier Plans Tier 4 (Specialty) Covered Yes
5-Tier Plans Tier 5 (Specialty) Covered Yes
Medicare Plans Tier 5 Covered Yes

Key formulary details:

  • Must be dispensed through specialty pharmacy (typically Accredo)
  • 30-day supply limits standard
  • No preferred alternatives in same class
  • Annual formulary reviews may affect placement

Prior Authorization Requirements

Cigna's prior authorization policy requires specific clinical criteria:

Required Documentation

  • Confirmed HAE diagnosis: Types I or II only (not type III)
  • Laboratory evidence:
    • Low functional C1-INH (<50% of normal)
    • Low serum C4 at baseline
  • Specialist prescription: Allergist, immunologist, or HAE specialist
  • Attack documentation: Frequency and severity logs
  • Prior therapy history: If applicable for step therapy requirements

Exclusion Criteria

  • HAE with normal C1-INH (type III)
  • Use for ACE-inhibitor induced angioedema
  • Concurrent use with other HAE prophylactics (Haegarda, Orladeyo)
Note: Initial approvals are typically granted for 12 months, with reauthorization requiring evidence of clinical benefit.

Specialty Pharmacy Requirements

Takhzyro must be dispensed through Cigna's designated specialty pharmacy network:

Primary Specialty Pharmacy

Accredo Specialty Pharmacy

  • Phone: 877-826-7657
  • Hours: Mon-Fri 7am-10pm CST, Sat 7am-4pm CST
  • Services: Home delivery, injection training, adherence support

Setup Process

  1. Provider submits PA approval to Cigna
  2. Upon approval, prescription automatically transfers to Accredo
  3. Accredo contacts patient to schedule delivery
  4. Initial consultation includes injection training
  5. Ongoing refill coordination and monitoring

Cost Sharing & Patient Expenses

Cost sharing varies significantly by plan design:

Typical Cost Structure

  • Deductible: Must be met before coverage begins
  • Coinsurance: 30-50% of drug cost after deductible
  • Out-of-pocket maximum: All costs count toward annual limit

Financial Assistance Options

  • Takeda OnePath: Manufacturer copay assistance program
  • HAE patient foundations: Various grant programs available
  • State programs: Florida may have additional assistance (verify with Florida Department of Health)
Important: With Takhzyro's wholesale cost around $26,353 per vial, even with insurance, patient costs can be substantial without assistance programs.

Step-by-Step Approval Process

1. Gather Required Documentation

Patient/Clinic: Collect lab results, attack logs, prior therapy records Timeline: 1-2 weeks Source: Cigna PA policy

2. Schedule Specialist Consultation

Patient: See allergist/immunologist if not already established Timeline: 1-4 weeks depending on availability Required: Must be in-network for HMO/EPO plans

3. Submit Prior Authorization

Provider: Submit through Cigna provider portal Timeline: Same day submission Include: All required documentation and medical necessity letter

4. Cigna Review Process

Cigna: Medical review of submission Timeline: 5-15 business days (standard), 24-72 hours (expedited) Decision: Approval, denial, or request for additional information

5. Prescription Setup

If approved: Automatic transfer to specialty pharmacy Timeline: 1-3 business days Patient contact: Accredo calls within 24-48 hours

6. First Fill Coordination

Accredo: Schedules delivery and training Timeline: 3-5 business days for first shipment Services: Injection training, storage instructions

7. Ongoing Management

Ongoing: Refill coordination and adherence monitoring Reauthorization: Required annually with clinical outcomes data

Common Denial Reasons & Solutions

Denial Reason Required Fix Documentation Needed
Insufficient HAE documentation Submit complete lab results C1-INH functional/antigenic, C4 levels
Missing specialist involvement Get specialist consultation Letter from allergist/immunologist
Inadequate attack documentation Provide detailed attack logs Frequency, severity, impact on daily life
Step therapy not met Document prior failures Records of previous HAE treatments
Duplicate therapy Discontinue other prophylactics Medication reconciliation

Medical Necessity Letter Checklist

Your specialist's letter should include:

  • Specific HAE type (I or II) with supporting labs
  • Attack frequency and impact on quality of life
  • Previous treatments tried and outcomes
  • Why Takhzyro is appropriate for this patient
  • Dosing rationale and monitoring plan
  • Reference to FDA prescribing information

Appeals Process in Florida

Internal Appeals (First Level)

  • Timeline: File within 180 days of denial
  • Process: Submit through Cigna appeals portal
  • Decision time: 30 days for pre-service, 60 days for post-service
  • Required: Denial letter, additional clinical evidence, physician letter

Internal Appeals (Second Level)

  • Timeline: 60 days after first-level denial
  • Review: Independent medical review
  • Decision time: 30 days
  • Options: Request peer-to-peer review with medical director

External Review (Florida)

  • Eligibility: After exhausting internal appeals
  • Timeline: 4 months from final internal denial
  • Process: File with Florida Department of Financial Services
  • Cost: Free to consumer
  • Decision: Binding on Cigna if overturned

Expedited Reviews

Available when delay could seriously jeopardize health:

  • Internal expedited: 24-72 hours
  • External expedited: 72 hours
  • Qualification: Life-threatening condition or severe symptom exacerbation

When to Escalate

Contact Florida regulators if you experience:

  • Repeated inappropriate denials
  • Failure to follow appeal timelines
  • Lack of response to expedited requests

Florida Department of Financial Services

  • Consumer Helpline: 1-877-MY-FL-CFO (877-693-5236)
  • Online complaints: Submit insurance concern
  • Services: Facilitate communication, ensure compliance with state law

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and drafts point-by-point rebuttals aligned to each plan's specific requirements, pulling the right medical evidence and clinical documentation to maximize approval chances. Visit CounterforceHealth.org to learn how we can help streamline your Takhzyro appeal process.

FAQ

Q: How long does Cigna prior authorization take for Takhzyro in Florida? A: Standard review takes 5-15 business days. Expedited review (for urgent cases) takes 24-72 hours.

Q: What if Takhzyro isn't on my formulary? A: You can request a formulary exception through Cigna's exception process, providing medical necessity documentation.

Q: Can I get an expedited appeal in Florida? A: Yes, if delay could seriously jeopardize your health. Both internal and external expedited reviews are available.

Q: Does step therapy apply if I failed treatments in another state? A: Yes, documented treatment failures from any location count toward step therapy requirements if properly documented.

Q: What happens if I switch from another HAE medication? A: You'll need to document the reason for switching and may need to discontinue other prophylactic therapies to avoid duplicate coverage issues.

Q: How much will Takhzyro cost with Cigna coverage? A: Costs vary by plan but typically involve meeting your deductible plus 30-50% coinsurance. Manufacturer assistance programs can significantly reduce out-of-pocket costs.

Q: Can I appeal if my doctor isn't an HAE specialist? A: Cigna requires prescription by an allergist, immunologist, or HAE specialist. You'll need to establish care with an appropriate specialist.

Q: What if Cigna requests additional information during review? A: Respond promptly with requested documentation. The review timeline pauses until you provide the additional information.

From our advocates: We've seen many Takhzyro appeals succeed when patients provide comprehensive attack logs showing frequency and severity. One effective approach is creating a simple chart tracking attack dates, affected body parts, duration, and impact on daily activities. This concrete evidence often makes the difference between approval and denial.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies may change, and individual circumstances vary. Always consult with your healthcare provider and verify current policy details with Cigna. For assistance with insurance appeals and complex coverage issues, platforms like Counterforce Health can provide specialized support in navigating prior authorization requirements and crafting effective appeals.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.